Patient pAML3 was a 16 year-old male diagnosed with the high-risk AML M5a subtype, with cytogenetics significant for MLL-MLLT4 (KMT2A-AFDN) fusion. The gene discussed is AFDN; the disease is acute myeloid leukemia.